Genoray Co., Ltd. (KOSDAQ:122310)
South Korea · Delayed Price · Currency is KRW 4,215.00
+125.00 (3.06%)
At close: Jan 23, 2026
Genoray Market Cap
Genoray has a market cap or net worth of 51.2 billion as of January 23, 2026. Its market cap has decreased by -27.41% in one year.
Market Cap
51.20B
Enterprise Value
72.42B
Revenue
102.75B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,215.00
Market Cap Chart
Since May 28, 2018, Genoray's market cap has decreased from 150.47B to 51.20B, a decrease of -65.97%. That is a compound annual growth rate of -13.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 51.20B | 1.32% |
| Dec 30, 2025 | 50.53B | -27.84% |
| Dec 30, 2024 | 70.03B | -26.75% |
| Dec 28, 2023 | 95.60B | -11.63% |
| Dec 29, 2022 | 108.18B | -23.55% |
| Dec 30, 2021 | 141.51B | 1.54% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| May 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Remed | 85.77B |
| QuantaMatrix | 84.20B |
| Hironic | 74.74B |
| JPI Healthcare | 70.00B |
| DRGEM | 58.07B |
| Neofect | 53.33B |
| UXN Co., Ltd. | 40.35B |
| CU Medical Systems | 35.35B |